BOSTON, Aug. 7 /PRNewswire/ -- Summer Street Research Partners, a
healthcare-dedicated investment firm, is pleased to announce the recent
closing of a financing for HeartWare, Ltd., a company developing ventricular
assist devices. HeartWare, a publicly traded company on the Australian Stock
Exchange (HTW), raised A$31 million and Summer Street Research Partners served
as co-U.S. placement agent. This is the second financing for HeartWare closed
by Summer Street Research Partners in the past 12 months. Al Sollami, Chief
Executive Officer of Summer Street Research Partners, commented, "Our two
closed financings for HeartWare, Ltd in difficult market environments evidence
are success in raising funds for high quality medical companies worldwide.
Common shares were placed amongst large well respected U.S. funds and we are
delighted to list HeartWare, Ltd. as one of our clients."
Contact:
Robert M. Goldman, CFA
Senior Managing Director and Head of Investment Banking
Summer Street Research Partners
617-532-6409
bobg@ssrp.com
.gif)
